Pulmonx, Corp. recalls Zephyr Endobronchial Valve (EBV) 5.5-LP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Endobronchial implant devices may have been labeled with a shortened expiration date but they can be used until the correct expiration date: 08 December 2024.
- Products
-
- Zephyr Endobronchial Valve (EBV) 5.5-LP
- Company
- Pulmonx, Corp.
- Where it was sold
-
US: TN, WV, AR, PA, VA, NC, IL, IA, MA, NY, NJ, WA, CO, OR, MI, FL, OH, TX, OK, AZ, NV, WI
States: Arkansas, Arizona, Colorado, Florida, Iowa, Illinois, Massachusetts, Michigan, North Carolina, New Jersey, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Virginia, Washington, Wisconsin, West Virginia
- Barcodes
00811907030423- Units affected
- 144
- About this recall
- Zephyr Endobronchial Valve (EBV) 5.5-LP, REF: EBV-TS-5.5-LP